72. Haubner F, Ohmann E, Pohl F, Strutz J, Gassner HG. Wound healing after radiation therapy: review of the literature. Radiat Oncol. 2012;7:162. doi: 10.1186/1748-717X-7-162.
73. Aizman L, Nelson K, Sparks AD, Friedman AJ. The Influence of Supportive Oncodermatology Interventions on Patient Quality of Life: A Cross-Sectional Survey. J Drugs Dermatol. 2020;19(5):477-482.
74. Chen ST, Molina GE, Lo JA, et al. Dermatology consultation reduces interruption of oncologic management among hospitalized patients with irAEs. J Am Acad Dermatol. 2020;82(4):994-996. doi: 10.1016/j. jaad.2019.09.026.
75. Barrios DM, Phillips GS, Feites-Martinez A, et al. Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study. J Eur Acad Dermatol Venereol. 2020;34(6):1340-1347. doi: 10.1111/ jdv.16159.
76. Barrios DCK, Phillips G, Lucas AS, et al. Anticancer therapy interruption and diagnostic concordance between referring clinicians and dermatologists at MSKCC. J Am Acad Dermatol. 2017;76(6):AB45. doi: 10.1016/j.jaad.2017.04.196.
77. Lucas AS, Ciccolini K. The role of oncodermatology in care of patients receiving cancer therapy. Seminars in Oncology Nursing. 2017;22(4):393-401. doi: 10.1016/j.soncn.2017.08.001.
78. Kwong BY. Outcomes of Embedding Dermatologic Care Within Oncology Practices for Patients With Cancer. J Am Med Assn Dermatol. 2020;156(10):1051-1052. doi:10.1001/jamadermatol.2020.1794.
79. Byrne J. Telemedicine in oncology: Virtual solution to a very real problem. Published April 25, 2019. Accessed September 2022. https:// www.healio.com/news/hematology-oncology/20190416/telemedicinein- oncology-virtual-solution-to-a-very-real-problem
73. Aizman L, Nelson K, Sparks AD, Friedman AJ. The Influence of Supportive Oncodermatology Interventions on Patient Quality of Life: A Cross-Sectional Survey. J Drugs Dermatol. 2020;19(5):477-482.
74. Chen ST, Molina GE, Lo JA, et al. Dermatology consultation reduces interruption of oncologic management among hospitalized patients with irAEs. J Am Acad Dermatol. 2020;82(4):994-996. doi: 10.1016/j. jaad.2019.09.026.
75. Barrios DM, Phillips GS, Feites-Martinez A, et al. Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study. J Eur Acad Dermatol Venereol. 2020;34(6):1340-1347. doi: 10.1111/ jdv.16159.
76. Barrios DCK, Phillips G, Lucas AS, et al. Anticancer therapy interruption and diagnostic concordance between referring clinicians and dermatologists at MSKCC. J Am Acad Dermatol. 2017;76(6):AB45. doi: 10.1016/j.jaad.2017.04.196.
77. Lucas AS, Ciccolini K. The role of oncodermatology in care of patients receiving cancer therapy. Seminars in Oncology Nursing. 2017;22(4):393-401. doi: 10.1016/j.soncn.2017.08.001.
78. Kwong BY. Outcomes of Embedding Dermatologic Care Within Oncology Practices for Patients With Cancer. J Am Med Assn Dermatol. 2020;156(10):1051-1052. doi:10.1001/jamadermatol.2020.1794.
79. Byrne J. Telemedicine in oncology: Virtual solution to a very real problem. Published April 25, 2019. Accessed September 2022. https:// www.healio.com/news/hematology-oncology/20190416/telemedicinein- oncology-virtual-solution-to-a-very-real-problem
AUTHOR CORRESPONDENCE
Anneke E. Andriessen PhD anneke.a@tiscali.nl